Spinal Restoration, Baxter in fibrin sealant partnership:
This article was originally published in Clinica
Minimally-invasive back pain therapy specialist Spinal Restoration has entered into an exclusive long-term agreement with Baxter Healthcare to develop and further expand the applications of the former's Biostat Biologx fibrin sealant. The deal will see Biostat Biologx combined with Baxter's own fibrin sealant to create the Biostat disc augmentation system, a minimally-invasive product for the treatment of painful degeneration of intervertebral discs. Spinal Restoration (Austin, Texas) said that the partnership will enable it to further its preparation for an investigational device exemption clinical study, scheduled for the first quarter of 2008.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.